It was also proposed that the G-1019 genotype of the 5-HT1A receptor might be associated with poorer treatment response and greater hippocampal atrophy, whereas the long allele of 5-HTTLPR might predict more favorable clinical outcomes. Here, HTR1A is linked to hippocampal atrophy.